骨矿物质代谢与肾性贫血关系的研究进展

发布时间：2018-05-23 12:04

本文选题：贫血 + 肾性骨营养障碍　；参考：《中国全科医学》2017年26期

【摘要】：肾性贫血是慢性肾脏病患者常见的并发症之一。近年来,越来越多的研究表明维生素D、成纤维细胞生长因子23(FGF23)、骨形态发生蛋白(BMPs)是参与骨矿物质代谢的分子,同样在肾性贫血的发生、发展中发挥作用。本文对维生素D、FGF23、BMPs与肾性贫血的关系进行综述,为进一步了解骨矿物质代谢紊乱与肾性贫血的内在联系以及为临床肾性贫血治疗提供新方向。
[Abstract]:Renal anemia is one of the common complications in patients with chronic kidney disease. In recent years, more and more studies have shown that vitamin D, fibroblast growth factor 23 (FGF23), bone morphogenetic protein (BMPs) are involved in bone mineral metabolism, and also play a role in the occurrence and development of renal anemia. This article reviews the relationship between vitamin D FGF23 BMPs and renal anemia in order to further understand the relationship between bone mineral metabolism disorder and renal anemia and to provide a new direction for clinical treatment of renal anemia.
【作者单位】：武汉大学人民医院肾内科;
【基金】：国家自然科学基金资助项目(81570617,81500516)
【分类号】：R556;R692

【相似文献】